KOTAI Biotechnologies Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.1M

KOTAI Biotechnologies General Information

Description

Provider of immuno-informatics services designed for drug discovery and clinical research. The company's services utilize ai-based big data analysis and three-dimensional molecular simulation to provide immune repertoire analysis, biomarker identification and target exploration, enabling pharmaceutical companies and research institutes to access novel therapeutic candidates and patient stratification data for cancer and autoimmune diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 7th Floor, Minoh Senri Building
  • 3-4-17 Senba Higashi
  • Minoh City, Osaka Prefecture 562-0035
  • Japan
+81
Primary Industry
Biotechnology
Parent Company
Corporate Office
  • 7th Floor, Minoh Senri Building
  • 3-4-17 Senba Higashi
  • Minoh City, Osaka Prefecture 562-0035
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KOTAI Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 31-Jul-2023 $7.1M Completed Generating Revenue
3. Later Stage VC (Series C) 28-Oct-2020 Completed Generating Revenue
2. Early Stage VC (Series B) 28-Aug-2017 $1.83M $2.32M Completed Startup
1. Early Stage VC (Series A) 21-Oct-2016 $487K $487K Completed Startup
To view KOTAI Biotechnologies’s complete valuation and funding history, request access »

KOTAI Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C preferred
B preferred
A preferred 2,500 $189.86 $189.86 1x $189.86 7.37%
To view KOTAI Biotechnologies’s complete cap table history, request access »

KOTAI Biotechnologies Patents

KOTAI Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024354738-A1 Coronavirus spike protein variants Pending 06-Oct-2023
EP-4790065-A1 Coronavirus spike protein variants Pending 06-Oct-2023
WO-2025075129-A1 Coronavirus spike protein variants Inactive 06-Oct-2023
JP-2022187385-A Antibodies against sars-cov-2 spike protein Pending 07-Jun-2021
EP-4310095-A1 Follicular helper t (tfh) cells specific to sars-cov-2 virus Inactive 16-Mar-2021 A61K39/12
To view KOTAI Biotechnologies’s complete patent history, request access »

KOTAI Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KOTAI Biotechnologies Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amashin-Shinkin Venture Capital Minority
Japan Agency for Medical Research and Development Government Minority
Minato Growing Enterprises Venture Capital Minority
New Energy and Industrial Technology Development Organization Government Minority
Nippon Venture Capital Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

KOTAI Biotechnologies FAQs

  • When was KOTAI Biotechnologies founded?

    KOTAI Biotechnologies was founded in 2016.

  • Where is KOTAI Biotechnologies headquartered?

    KOTAI Biotechnologies is headquartered in Minoh City, Japan.

  • What is the size of KOTAI Biotechnologies?

    KOTAI Biotechnologies has 11 total employees.

  • What industry is KOTAI Biotechnologies in?

    KOTAI Biotechnologies’s primary industry is Biotechnology.

  • Is KOTAI Biotechnologies a private or public company?

    KOTAI Biotechnologies is a Private company.

  • What is the current valuation of KOTAI Biotechnologies?

    The current valuation of KOTAI Biotechnologies is .

  • What is KOTAI Biotechnologies’s current revenue?

    The current revenue for KOTAI Biotechnologies is .

  • How much funding has KOTAI Biotechnologies raised over time?

    KOTAI Biotechnologies has raised $4.79M.

  • Who are KOTAI Biotechnologies’s investors?

    Amashin-Shinkin, Japan Agency for Medical Research and Development, Minato Growing Enterprises, New Energy and Industrial Technology Development Organization, and Nippon Venture Capital are 5 of 8 investors who have invested in KOTAI Biotechnologies.

  • When was KOTAI Biotechnologies acquired?

    KOTAI Biotechnologies was acquired on 31-Jul-2023.

  • Who acquired KOTAI Biotechnologies?

    KOTAI Biotechnologies was acquired by Sanyo Trading Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process